Literature DB >> 26113383

Zero-inflated count models for longitudinal measurements with heterogeneous random effects.

Huirong Zhu1, Sheng Luo1, Stacia M DeSantis1.   

Abstract

Longitudinal zero-inflated count data arise frequently in substance use research when assessing the effects of behavioral and pharmacological interventions. Zero-inflated count models (e.g. zero-inflated Poisson or zero-inflated negative binomial) with random effects have been developed to analyze this type of data. In random effects zero-inflated count models, the random effects covariance matrix is typically assumed to be homogeneous (constant across subjects). However, in many situations this matrix may be heterogeneous (differ by measured covariates). In this paper, we extend zero-inflated count models to account for random effects heterogeneity by modeling their variance as a function of covariates. We show via simulation that ignoring intervention and covariate-specific heterogeneity can produce biased estimates of covariate and random effect estimates. Moreover, those biased estimates can be rectified by correctly modeling the random effects covariance structure. The methodological development is motivated by and applied to the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study, the largest clinical trial of alcohol dependence performed in United States with 1383 individuals.

Entities:  

Keywords:  Zero-inflation model; count data; heterogeneity; negative binomial; random effects modeling

Mesh:

Year:  2015        PMID: 26113383      PMCID: PMC5045322          DOI: 10.1177/0962280215588224

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  29 in total

1.  Linear mixed models with flexible distributions of random effects for longitudinal data.

Authors:  D Zhang; M Davidian
Journal:  Biometrics       Date:  2001-09       Impact factor: 2.571

2.  Smooth random effects distribution in a linear mixed model.

Authors:  Wendimagegn Ghidey; Emmanuel Lesaffre; Paul Eilers
Journal:  Biometrics       Date:  2004-12       Impact factor: 2.571

3.  Modeling heterogeneity for count data: A study of maternal mortality in health facilities in Mozambique.

Authors:  Osvaldo Loquiha; Niel Hens; Leonardo Chavane; Marleen Temmerman; Marc Aerts
Journal:  Biom J       Date:  2013-07-05       Impact factor: 2.207

4.  Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study.

Authors:  Ralitza Gueorguieva; Ran Wu; Dennis Donovan; Bruce J Rounsaville; David Couper; John H Krystal; Stephanie S O'Malley
Journal:  Drug Alcohol Depend       Date:  2009-12-06       Impact factor: 4.492

5.  A two-part mixed-effects pattern-mixture model to handle zero-inflation and incompleteness in a longitudinal setting.

Authors:  Antonello Maruotti
Journal:  Biom J       Date:  2011-08-24       Impact factor: 2.207

6.  Linear mixed models with heterogeneous within-cluster variances.

Authors:  X Lin; J Raz; S D Harlow
Journal:  Biometrics       Date:  1997-09       Impact factor: 2.571

7.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Authors:  Raymond F Anton; Stephanie S O'Malley; Domenic A Ciraulo; Ron A Cisler; David Couper; Dennis M Donovan; David R Gastfriend; James D Hosking; Bankole A Johnson; Joseph S LoCastro; Richard Longabaugh; Barbara J Mason; Margaret E Mattson; William R Miller; Helen M Pettinati; Carrie L Randall; Robert Swift; Roger D Weiss; Lauren D Williams; Allen Zweben
Journal:  JAMA       Date:  2006-05-03       Impact factor: 56.272

8.  A Bayesian model for repeated measures zero-inflated count data with application to outpatient psychiatric service use.

Authors:  Brian H Neelon; A James O'Malley; Sharon-Lise T Normand
Journal:  Stat Modelling       Date:  2010-12       Impact factor: 2.039

9.  A joint model of longitudinal and competing risks survival data with heterogeneous random effects and outlying longitudinal measurements.

Authors:  Xin Huang; Gang Li; Robert M Elashoff
Journal:  Stat Interface       Date:  2010       Impact factor: 0.582

10.  Gender and alcohol consumption: patterns from the multinational GENACIS project.

Authors:  Richard W Wilsnack; Sharon C Wilsnack; Arlinda F Kristjanson; Nancy D Vogeltanz-Holm; Gerhard Gmel
Journal:  Addiction       Date:  2009-09       Impact factor: 6.526

View more
  8 in total

1.  Legalization of recreational marijuana and community sales policy in Oregon: Impact on adolescent willingness and intent to use, parent use, and adolescent use.

Authors:  Julie C Rusby; Erika Westling; Ryann Crowley; John M Light
Journal:  Psychol Addict Behav       Date:  2017-11-16

2.  Robust inference in the multilevel zero-inflated negative binomial model.

Authors:  Eghbal Zandkarimi; Abbas Moghimbeigi; Hossein Mahjub; Reza Majdzadeh
Journal:  J Appl Stat       Date:  2019-07-02       Impact factor: 1.416

3.  A doubly-inflated Poisson regression for correlated count data.

Authors:  Erfan Ghasemi; Alireza Akbarzadeh Baghban; Farid Zayeri; Asma Pourhoseingholi; Seyed Mohammadreza Safavi
Journal:  J Appl Stat       Date:  2020-05-01       Impact factor: 1.416

4.  Joint modeling of longitudinal zero-inflated count and time-to-event data: A Bayesian perspective.

Authors:  Huirong Zhu; Stacia M DeSantis; Sheng Luo
Journal:  Stat Methods Med Res       Date:  2016-07-26       Impact factor: 3.021

5.  Models for analyzing zero-inflated and overdispersed count data: an application to cigarette and marijuana use.

Authors:  Brian Pittman; Eugenia Buta; Suchitra Krishnan-Sarin; Stephanie S O'Malley; Thomas Liss; Ralitza Gueorguieva
Journal:  Nicotine Tob Res       Date:  2018-04-18       Impact factor: 4.244

6.  The BNT162b2 vaccine is associated with lower new COVID-19 cases in nursing home residents and staff.

Authors:  Marsida Domi; Michael Leitson; David Gifford; Anna Nicolaou; Kiran Sreenivas; Courtney Bishnoi
Journal:  J Am Geriatr Soc       Date:  2021-05-18       Impact factor: 7.538

7.  Intent-to-treat analysis of cluster randomized trials when clusters report unidentifiable outcome proportions.

Authors:  Stacia M DeSantis; Ruosha Li; Yefei Zhang; Xueying Wang; Sally W Vernon; Barbara C Tilley; Gary Koch
Journal:  Clin Trials       Date:  2020-08-24       Impact factor: 2.599

8.  Population-Based Pharmacokinetic and Exposure-Efficacy Analyses of Peginterferon Beta-1a in Patients With Relapsing Multiple Sclerosis.

Authors:  Xiao Hu; Yaming Hang; Yue Cui; Jie Zhang; Shifang Liu; Ali Seddighzadeh; Aaron Deykin; Ivan Nestorov
Journal:  J Clin Pharmacol       Date:  2017-04-10       Impact factor: 3.126

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.